Minocycline, a semi-synthetic tetracycline with anti-inflammatory and anti-apoptotic properties, inhibits MMP-9 activity and has shown neuroprotection in cerebral ischemia and in other models of brain injury [87,89,90]. The gene discussed is MMP9; the disease is Cerebral ischemia.